{"database": "openregs", "table": "dockets", "rows": [["FDA-2006-P-0201", "FDA", "Determine whether Eloxatin (Oxaliplatin for Injection) 50 mg and 100 mg sterile lyophilized powder vials (NDA #21-492 has been withdrawn for safety or effectiveness reasons", "Nonrulemaking", "2021-09-01T01:01:32Z", "0b00006480450f37"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2006-P-0201"], "units": {}, "query_ms": 0.27998187579214573, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}